Table 2 Clinical and CSF characteristics in VPSV and VPSWOV patients pre-operation

Sex(M/F)

12/1

6/4

0.127

Age(Y) median (range)

28(17–53)

41(17–61)

0.032

Symptoms duration,

days, median (range)

90 (20–180)

30(10–180)

0.019

 headache

11/13 (84.6%)

10(100%)

0.486

 fever

7/13(53.8%)

5/10(50%)

>0.999

 Vomiting

8/13(61.5%)

8/10(80%)

0.405

 Visual symptoms

7/13(53.8%)

7/10(70%)

0.669

 Auditory symptom

2/13(15.4%)

3/10(30%)

0.618

Altered mental status

5/13(38.5%)

3/10(30%)

>0.999

 Seizure

1/13(7.69%)

2/10(20%)

0.560

Indian ink smear (+)

12/13(92.3%)

10/10(100%)

>0.999

CSF culture positive (+)

8/13(61.5%)

7/10(70%)

>0.999

Time to operation(m)

3.5(1.5–6)

2(0.5–4)

0.028

CSF pressure (mmH2O) median (range)

330(200–1020)

330(204–660)

0.059

WBC count(×106/l) median (range)

60(0–550)

36(1–496)

0.225

Protein, g/L median (range)

0.53(0.12–4.06)

0.8(0.23–1.62)

0.139

Glucose(mmol/l) median (range)

2.33(0.01–5.58)

2.53(0.23–5.7)

0.753

Chloride(mmol/l) median (range)

118(103–133)

120(108–136)

0.150

India ink Cryptococcus count

23(0–1.3E4)

1.94E3(4–1.67E5)

0.001